Abstract:Oxidized low-density lipoprotein (ox-LDL) can impair endothelial function and lead to the atherosclerosis development. Protein S-nitrosylation is sensitive to cellular redox state and acts as a crucial regulator and executor of nitric oxide (NO) signaling pathways. Aberrant S-nitrosylation contributes to the pathogenesis of cardiovascular and cerebrovascular diseases. However, the effect of ox-LDL on S-nitrosylation and its significance for endothelial dysfunction have not been studied at proteome level. Herein, the combined quantitative analysis of proteome and S-nitrosoproteome was performed using an integrated biotin switch and iTRAQ labeling approach in EA.hy926 cell line derived from human umbilical vein endothelial cell (HUVEC) treated with ox-LDL. A total of 2204 S-nitrosylated (SNO) peptides of 1318 SNO-proteins were quantified. Notably, 352 SNO-peptides of 262 SNO-proteins were significantly regulated after excluding S-nitrosylation changes caused by protein expression alterations. Many of them belonged to mRNA splicing, ribosomal structure and translational regulatory proteins, covering the entire translation process. The results indicated that S-nitrosylation of the splicing and translational machinery in vascular endothelial cells was susceptible to ox-LDL. Abnormal protein S-nitrosylation may be one pivotal mechanism underlying endothelial dysfunction induced by ox-LDL. This study potentially enriches the present understanding of pro-atherogenic effect of ox-LDL from the perspective of S-nitrosylation. SIGNIFICANCE: The role of ox-LDL in endothelial dysfunction and atherosclerosis development has been recognized from the aspect of impaired NO production. However, its effect on S-nitrosylation, which is directly related to NO signaling pathway, still remains largely unexplored. Our work initially provided a systematic characterization of S-nitrosoproteome in ox-LDL-treated endothelial cells after ruling out the changes of S-nitrosylation modification caused by protein expression alone. MS-based approach coupled with iTRAQ technique indicated 262 SNO-proteins were significantly regulated. Functional enrichment and interaction network analysis revealed that proteins involved in mRNA splicing and translational machinery were susceptible to abnormal S-nitrosylation under ox-LDL treatment. This achievement suggested one potential mechanism underlying endothelial dysfunction induced by ox-LDL from the perspective of S-nitrosoproteome.

olecular-Weight S-Nitrosothiols and S-Nitrosylated uman Serum Albumin

Biological Chemistry and Clinical Application of Nitrosothiols

Proteomic Analysis of Cellular Responses to Low Concentration N‐methyl‐N′‐nitro‐N‐nitrosoguanidine in Human Amnion FL Cells

Altered Expression of Zinc Finger Proteins, ADAMs, and Integrin‐related Proteins Following Treatment of Cultured Human Cells with a Low Concentration of N‐methyl‐N′‐nitro‐N‐nitrosoguanidine

Mass Spectrometry Analysis of Nitrotyrosine‐containing Proteins

Equilibrium and kinetics studies of transnitrosation between S-nitrosothiols and thiols.

Mass spectrometry analysis of nitrotyrosine-containing proteins.

Mass spectrometry analysis of S-nitrosylation of proteins and its role in cancer, cardiovascular and neurodegenerative diseases

Skeletal Muscle Aldolase an Overexpression in Endotoxemic Rats and Inhibited by GSNO Via Potential Role for S-nitrosylation in Vitro.

The oxido-redox potential of albumin methodological approach and relevance to human diseases

Optimization of the Isolation and Enrichment of S-Nitrosylated Proteins from Brain Tissues of Rodents and Humans with Various Prion Diseases for Itraq-Based Proteomics

A proteomic study of S-nitrosylation in the rat cardiac proteins in vitro.

The Protein S-nitrosylation of Splicing and Translational Machinery in Vascular Endothelial Cells is Susceptible to Oxidative Stress Induced by Oxidized Low-Density Lipoprotein.

Two-dimensional nitrosylated protein fingerprinting by using poly (methyl methacrylate) microchips

Systematic analysis of the global characteristics and reciprocal effects of S-nitrosylation and S-persulfidation in the human proteome

Automated Online Solid-Phase Derivatization for Sensitive Quantification of Endogenous S-Nitrosoglutathione and Rapid Capture of Other Low-Molecular-Mass S-Nitrosothiols

Relative quantitation of chiral thiol compounds labeled based on isotope novel mass spectrometry probes: Monitoring of the dynamic changes of chiral thiol compounds in human urine during normal, exercise, and rest recovery states

FluoroTRAQ: Quantitative Analysis of Protein S-Nitrosylation Through Fluorous Solid-Phase Extraction Combining with Itraq by Mass Spectrometry

Identification of Protein Targets of S -Nitroso-Coenzyme A-Mediated S -Nitrosation Using Chemoproteomics

Protein S-Nitrosation: Biochemistry, Identification, Molecular Mechanisms, and Therapeutic Applications

Analytical Methods for Assessing Thiol Antioxidants in Biological Fluids: A Review